Research Topics
Genomes and Genes | Stephen LamSummaryAffiliation: British Columbia Country: Canada Publications
Research Grants
| Collaborators
|
Detail Information
Publications
In vivo optical coherence tomography imaging of preinvasive bronchial lesionsStephen Lam
Cancer Imaging Department, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada
Clin Cancer Res 14:2006-11. 2008..The objective of the study was to determine if OCT could characterize preneoplastic changes in the bronchial epithelium identified by autofluorescence bronchoscopy...
A phase I study of myo-inositol for lung cancer chemopreventionStephen Lam
Department of Respiratory Medicine, British Columbia Cancer Agency, British Columbia, Canada
Cancer Epidemiol Biomarkers Prev 15:1526-31. 2006..A phase I, open-label, multiple dose, dose-escalation clinical study was conducted to assess the safety, tolerability, maximum tolerated dose, and potential chemopreventive effect of myo-inositol in smokers with bronchial dysplasia...
A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epitheliumStephen Lam
Department of Respiratory Medicine, British Columbia Cancer Agency and the University of British Columbia, Vancouver, British Columbia, Canada
Clin Cancer Res 10:6502-11. 2004..Preclinical studies suggest that inhaled budesonide may be an effective chemopreventive agent for lung cancer. We conducted a phase IIb study to determine the effects of inhaled budesonide in smokers with bronchial dysplasia...
Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsiesJay W Tichelaar
Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
BMC Cancer 5:155. 2005..The acquisition of anti-apoptotic signals is critical for the survival of cancer cells but the pathways involved are incompletely characterized in developing intra-epithelial neoplasia (IEN)...
Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinomaWilliam W Lockwood
Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
PLoS Med 7:e1000315. 2010..Identification of the molecular differences between these tumor types will have a significant impact in designing novel therapies that can improve the treatment outcome...
Genetic disruption of KEAP1/CUL3 E3 ubiquitin ligase complex components is a key mechanism of NF-kappaB pathway activation in lung cancerKelsie L Thu
Integrative Oncology Department, BC Cancer Research Centre, Vancouver, Canada
J Thorac Oncol 6:1521-9. 2011..We investigated complex component gene disruption as a novel genetic mechanism of NF-κB activation in non-small cell lung cancer...
Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGEKim M Lonergan
Genetics Unit, Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
PLoS ONE 5:e9162. 2010..Identification of biological pathways reflective of these progressive stages, and aberrantly expressed genes associated with these pathways, would conceivably enhance therapeutic approaches to this devastating disease...
Surrogate end-point biomarker analysis in a retinol chemoprevention trial in current and former smokers with bronchial dysplasiaStephen Lam
Department of Respiratory Therapy, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 3J5, Canada
Int J Oncol 23:1607-13. 2003....
High resolution analysis of non-small cell lung cancer cell lines by whole genome tiling path array CGHCathie Garnis
British Columbia Cancer Research Centre, Vancouver, BC, Canada
Int J Cancer 118:1556-64. 2006..In summary, our data demonstrate the unique information generated by high resolution analysis of NSCLC genomes and uncover the presence of genetic alterations prevalent in the different NSCLC subtypes...
Using laser Raman spectroscopy to reduce false positives of autofluorescence bronchoscopies: a pilot studyMichael A Short
Cancer Imaging Unit, Integrative Oncology Department, British Columbia Cancer Agency Research Centre, University of British Columbia, Vancouver, British Columbia, Canada
J Thorac Oncol 6:1206-14. 2011....
Surfactant protein D and bronchial dysplasia in smokers at high risk of lung cancerDon D Sin
St Paul s Hospital, 1081 Burrard Street, Vancouver, BC, Canada
Chest 134:582-8. 2008..Surfactant dysfunction has been implicated in both lung cancer and COPD. This study evaluated the relationship between surfactant protein D (SP-D) and the progression of bronchial dysplasia in heavy smokers...
Development and preliminary results of an endoscopic Raman probe for potential in vivo diagnosis of lung cancersMichael A Short
Cancer Imagin Department, British Columbia Cancer Research Centre, Vancouver, B C, Canada
Opt Lett 33:711-3. 2008..Preliminary clinical tests show that clear and reliable Raman spectra can be obtained...
Effect of active smoking on the human bronchial epithelium transcriptomeRaj Chari
Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre, Vancouver, BC, Canada
BMC Genomics 8:297. 2007....
High-resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell linesBradley P Coe
British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
Genes Chromosomes Cancer 42:308-13. 2005....
Gain of a region on 7p22.3, containing MAD1L1, is the most frequent event in small-cell lung cancer cell linesBradley P Coe
British Columbia Cancer Research Centre, Vancouver, BC, Canada
Genes Chromosomes Cancer 45:11-9. 2006..Intriguingly, MAD1L1 has been implicated to have tumor-suppressing functions. Our data suggest a more complex role for this gene, as MAD1L1 is the most frequent copy number gain in SCLC cell lines...
Nuclear morphometry as a biomarker for bronchial intraepithelial neoplasia: correlation with genetic damage and cancer developmentMartial Guillaud
Department of Cancer Imaging, Vancouver, British Columbia, Canada
Cytometry A 63:34-40. 2005..CONCLUSIONS: In chemoprevention trials, nuclear morphometry can supplement histopathology as a Surrogate Endpont Biomarker (SEB) because it is quantitative, collelates well with genetic damage, and may predict cancer development...
A sequence-based approach to identify reference genes for gene expression analysisRaj Chari
Department of Integrative Oncology, British Columbia Cancer Agency Research Centre, Vancouver, BC, Canada
BMC Med Genomics 3:32. 2010..Alternatively, as sequencing-based technologies provide digital quantitative output, absolute quantification ensues, and reference gene identification becomes more accurate...
Lung cancer screening: a different paradigmAnnette McWilliams
British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6 Canada
Am J Respir Crit Care Med 168:1167-73. 2003..1%. CT scan alone would have missed 29% of the cancers. This screening paradigm shift has the additional potential of reducing the number of initial CT scans by at least 25% with further savings in follow-up investigations and treatment...
Divergent genomic and epigenomic landscapes of lung cancer subtypes underscore the selection of different oncogenic pathways during tumor developmentWilliam W Lockwood
Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
PLoS ONE 7:e37775. 2012..Together, our findings suggest that AC and SqCC develop through distinct pathogenetic pathways that have significant implication in our approach to the clinical management of NSCLC...
Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instabilityKelsie L Thu
Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada
PLoS ONE 7:e33003. 2012..Collectively, our findings provide evidence that these lung tumors are globally and genetically different, which implies they are likely driven by distinct molecular mechanisms...
Patient-derived first generation xenografts of non-small cell lung cancers: promising tools for predicting drug responses for personalized chemotherapyXin Dong
Department of Cancer Endocrinology, BC Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada
Clin Cancer Res 16:1442-51. 2010..In this study, first generation subrenal capsule xenografts of primary NSCLCs were examined for (a) determining responses to conventional chemotherapeutic regimens and (b) selecting regimens most effective for individual patients...
The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazineJun Guan
Department of Cancer Endocrinology, BC Cancer Agency, Research Centre, Vancouver, BC, Canada
Cancer Chemother Pharmacol 64:463-72. 2009..To determine whether the xc- cystine transporter could be a useful therapeutic target for small-cell lung cancer (SCLC)...
Integrating the multiple dimensions of genomic and epigenomic landscapes of cancerRaj Chari
Genetics Unit Department of Integrative Oncology, British Columbia Cancer Research Centre, Vancouver, BC, Canada
Cancer Metastasis Rev 29:73-93. 2010....
Identification of novel lung genes in bronchial epithelium by serial analysis of gene expressionKim M Lonergan
Cancer Genetics and Developmental Biology, Department of Cancer Imaging, Canada s Michael Smith Genome Sciences Centre, British Columbia Cancer Research Centre, Vancouver, BC, Canada
Am J Respir Cell Mol Biol 35:651-61. 2006....
TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancerDaniel T Starczynowski
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
J Clin Invest 121:4095-105. 2011..Our findings show that TRAF6 is an oncogene that is important for RAS-mediated oncogenesis and provide a mechanistic explanation for the previously apparent importance of constitutive NF-κB activation in RAS-driven lung cancers...
Human cancer long non-coding RNA transcriptomesEwan A Gibb
British Columbia Cancer Agency Research Centre, Vancouver, British Columbia, Canada
PLoS ONE 6:e25915. 2011..Our findings show extensive, tissue-specific lncRNA expression in normal tissues and highly aberrant lncRNA expression in human cancers. Here, we present a first generation atlas for lncRNA profiling in cancer...
miR-101 DNA copy loss is a prominent subtype specific event in lung cancerKelsie L Thu
BC Cancer Research Centre, Vancouver, British Columbia, Canada
J Thorac Oncol 6:1594-8. 2011..miR-101 is encoded at two loci in the human genome: 1p31.3 (miR-101-1) and 9p24.1 (miR-101-2). We sought to investigate miR-101 locus-specific deletions and genomic loss in the major subtypes of lung cancer...
Airway wall thickness assessed using computed tomography and optical coherence tomographyHarvey O Coxson
Department of Radiology, Vancouver General Hospital, 855 West 12th Avenue, Room 3350 JPN, Vancouver, BC, Canada
Am J Respir Crit Care Med 177:1201-6. 2008..Optical coherence tomography (OCT) is a promising new micron-scale resolution imaging technique that can image small airways 2 mm in diameter or less...
Confocal fluorescence microendoscopy of bronchial epitheliumPierre M Lane
British Columbia Cancer Research Center, Cancer Imaging Department, 675 West 10th Avenue, Vancouver, BC V5Z 1 L3, Canada
J Biomed Opt 14:024008. 2009..However, further improvements in the miniature objective lens are required to provide sufficient axial resolution for accurate classification of preneoplastic lesions...
Detection sensitivity of a commercial lung nodule CAD system in a series of pathologically proven lung cancersMyrna C B Godoy
Department of Radiology, St Paul s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
J Thorac Imaging 23:1-6. 2008..To evaluate the performance of a commercially available computer-aided detection (CAD) system in a series of pathologically proven lung cancers...
Near-infrared Raman spectroscopy for optical diagnosis of lung cancerZhiwei Huang
Photomedicine and Optics Research Laboratory, Cancer Imaging Department, British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, B.C. V5Z 1L3, Canada
Int J Cancer 107:1047-52. 2003..0001). The results of this exploratory study indicate that NIR Raman spectroscopy provides significant potential for the noninvasive diagnosis of lung cancers in vivo based on the optic evaluation of biomolecules...
A randomized phase IIb trial of anethole dithiolethione in smokers with bronchial dysplasiaStephen Lam
Department of Respiratory Medicine, British Columbia Cancer Agency and the University of British Columbia, Vancouver, Canada
J Natl Cancer Inst 94:1001-9. 2002..We conducted a phase IIb study to determine the effects of ADT in smokers with bronchial dysplasia...
Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesisCathie Garnis
British Columbia Cancer Research Centre, Vancouver, BC V5Z 1L3, Canada
Hum Mol Genet 14:475-82. 2005..Importantly, this implication of pathways known only to be activated in fetal lung development lends support to the proposed model of lung cancer ontology whereby tumors arise from dysregulated pleuripotent stem cells...
Key issues in lung cancer chemoprevention trials of new agentsStephen Lam
Lung Tumour Group, The British Columbia Cancer Agency and The University of British Columbia, West 10 Avenue, Vancouver, BC V5Z 4E6, Canada
Recent Results Cancer Res 163:182-95; discussion 264-6. 2003..Novel imaging methods such as confocal micro-endoscopy and spiral CT-directed endoscopic biopsies are under development to evaluate the response of chemopreventive agents on peripheral pre-neoplastic lesions in small airways...
A framework for quantitative assessment of Ki67 distribution in preneoplastic bronchial epithelial lesionsMehrnoush Khojasteh
Department of Cancer Imaging, British Columbia Cancer Research Center, Vancouver, British Columbia, Canada
Anal Quant Cytol Histol 34:120-38. 2012..We sought to develop a robust, objective means of quantitatively evaluating Ki67 immunostaining for lung precancerous lesions...
New and current clinical imaging techniques to study chronic obstructive pulmonary diseaseHarvey O Coxson
Providence Heart and Lung Institute, St Paul s Hospital, Vancouver, British Columbia, Canada
Am J Respir Crit Care Med 180:588-97. 2009..In this article, we provide an overview of these imaging modalities in the context of COPD and discuss their strengths as well as their limitations for providing quantitative COPD phenotypes...
MicroRNA gene dosage alterations and drug response in lung cancerKatey S S Enfield
British Columbia Cancer Research Centre, Vancouver, BC, Canada
J Biomed Biotechnol 2011:474632. 2011....
In vitro model for studying malignancy associated changesXiao Rong Sun
Cancer Imaging Department, British Columbia Cancer Agency, Vancouver, Canada
Anal Cell Pathol 25:95-102. 2003..This study provides evidence in support to the hypothesis that MAC are induced by a soluble factor(s) released by malignant cells. Colour figure can be viewed on http://www.esacp.org/acp/2003/25-2/sun.htm..
Lung cancer screeningAnnette McWilliams
British Columbia Cancer Agency, Vancouver, Canada
Curr Opin Pulm Med 11:272-7. 2005....
Automated sputum cytometry for detection of intraepithelial neoplasias in the lungGerald Li
Integrative Oncology Department, BC Cancer Research Centre, Vancouver, Canada
Anal Cell Pathol (Amst) 35:187-201. 2012..Our novel sputum biomarker, the Combined Score (CS), uses automated image cytometric analysis of ploidy and nuclear morphology to detect subtle intraepithelial changes that often precede lung tumours...
Early detection and chemoprevention of lung cancerTawimas Shaipanich
Department of Respiratory Medicine, British Columbia Cancer Agency, Vancouver, Canada
Respirology 11:366-72. 2006..The current status of chemoprevention is summarized. The case for using a two-step screening strategy is also discussed...
Integrated endoscopy system for simultaneous imaging and spectroscopy for early lung cancer detectionHaishan Zeng
Cancer Imaging Department, BC Cancer Agency, 601 West 10th Avenue, Vancouver, British Columbia V5Z 1L3, Canada
Opt Lett 29:587-9. 2004..The system has been successfully tested in a clinic, demonstrating a practical approach to improve both diagnostic sensitivity and specificity at the same time...
New approaches to lung cancer preventionAnnette McWilliams
Lung Tumor Group, British Columbia Cancer Agency, University of British Columbia, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6
Curr Oncol Rep 4:487-94. 2002..More accurate surrogate endpoint biomarkers are becoming available for phase II trials of new agents. A number of promising agents are currently being tested in phase II and III trials for prevention of lung cancer...
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cellsMaria M Ho
Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada
Cancer Res 67:4827-33. 2007..These findings indicate that SP is an enriched source of lung tumor-initiating cells with stem cell properties and may be an important target for effective therapy and a useful tool to investigate the tumorigenic process...
Effect of formalin fixation on the near-infrared Raman spectroscopy of normal and cancerous human bronchial tissuesZhiwei Huang
Cancer Imaging Department, British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, BC, Canada V5Z 1L3
Int J Oncol 23:649-55. 2003..If only fixed tissue is available, thorough rinsing of specimens in phosphate-buffered saline (PBS) before spectral measurements may help reduce the formalin fixation artifacts on tissue Raman spectra...
The relationship between stage 1 and 2 non-small cell lung cancer and lung function in men and womenSamir Malhotra
Respiratory Division, Department of Medicine, University of British Columbia, British Columbia, Canada
BMC Pulm Med 6:2. 2006..Using a large tissue registry, we sought to determine the relationship between FEV1 and subtypes of NSCLC and determine whether this relationship is modified by gender...
Establishment in severe combined immunodeficiency mice of subrenal capsule xenografts and transplantable tumor lines from a variety of primary human lung cancers: potential models for studying tumor progression-related changesJean-Claude Cutz
Department of Cancer Endocrinology, BC Cancer Agency, Vancouver, British Columbia, Canada
Clin Cancer Res 12:4043-54. 2006..The transplantable tumor lines seem to provide good models for studying various aspects of tumor progression and a platform for developing novel therapeutic regimens, with the possibility of patient-tailored therapies...
Increase of sensitivity of sputum cytology using high-resolution image cytometry: field study resultsBranko Palcic
British Columbia Cancer Agency, 191-828 West 10th Street, Vancouver, British Columbia V5Z 1L8, Canada
Cytometry 50:168-76. 2002..Cytometry (Clin. Cytometry) 50:168-176, 2002...
Arsenic, asbestos and radon: emerging players in lung tumorigenesisRoland Hubaux
British Columbia Cancer Research Centre, Vancouver, BC, V5Z 1L3, Canada
Environ Health 11:89. 2012..A better understanding of the mode of action of these carcinogens will facilitate the prevention and management of lung cancer related to such environmental hazards...
What to do when a smoker's CT scan is "normal"?: Implications for lung cancer screeningJoanna H Zurawska
Department of Medicine, Division of Respiratory Medicine, University of British Columbia, BC, Canada
Chest 141:1147-52. 2012..In this article, we offer a possible low-cost strategy to risk-stratify smokers on the basis of spirometry measurements and emphysema scoring by radiologists on CT scans...
Construction and optimization of chromosome arm-specific comparative genomic hybridization arrays for identifying genetic alterations in preinvasive lung cancersCathie Garnis
British Columbia Cancer Research Centre, Vancouver, BC, Canada
Chest 125:104S-5S. 2004
The effects of radiation dose and CT manufacturer on measurements of lung densitometryRen Yuan
Department of Radiology, Vancouver General Hospital, 855 West Twelfth Ave, Room 3350 JPN, Vancouver, BC, Canada
Chest 132:617-23. 2007..To evaluate the effect of radiation dose and scanner manufacturer on quantitative CT scan measurements of lung morphology in smokers...
EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancerStephen Lam
Department of Pulmonary Medicine, British Columbia Cancer Agency, Vancouver, Canada
Cancer Prev Res (Phila) 4:1126-34. 2011..These studies confirm the value of an autoantibody assay, EarlyCDT-Lung, as an aid to detecting lung cancer in patients at high risk of the disease...
Research Grants
- A Phase II Trial of ACAPHA in Former Smokers with IEN.Stephen Lam; Fiscal Year: 2006..It will also provide new information on the use of novel biomarkers as surrogate endpoints for assessing the effect of chemoprevention. ..
